pipette
ESEspañol

Metabolic rewiring induces a viral mimicry-mediated quiescence in glioblastoma

C. Chesnelong, K. Desai, C. S. Charton, M. Kushida, C. Yu, P. Guilhamon, L. Lee, S. Agnihotri, P. B. Dirks

Preprint

In the authors' words

Glioblastoma is a highly aggressive brain tumour driven by therapy-resistant glioblastoma stem cells (GSCs) that switch between dormant and proliferative states through poorly defined programs. In this study, we identify SAT1, encoding the rate-limiting polyamine-catabolic enzyme SSAT1, as enriched in quiescent GSCs, linking metabolic rewiring to dormancy. Pharmacologic induction of SSAT1 with the polyamine analogue N1,N11-Diethylnorspermine (DENSpm) triggers a chemoprotective, reversible growth arrest in patient-derived GSCs, independent of stemness, differentiation or senescence. SAT1-induced dormancy coincides with reduced eIF5A hypusination and global protein translation, and a marked rise in double-stranded RNA that activates type I interferon signalling. Knocking down the mitochondrial antiviral-signalling protein, essential for antiviral innate immunity, partially reverses this growth arrest, establishing viral mimicry as functionally required for dormancy. Single-cell and cohort analyses across GSCs and neural stem cells demonstrate that susceptibility to metabolically induced quiescence is set by an intrinsic inflammatory tone and lysosomal dependency, defining a context-dependent metabolic-immune axis which can be targeted to prevent GBM progression.

Main resultThe abstract does not state a limitation.

Appeared: Tuesday, October 6. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.01.755088